Eikon Therapeutics, Inc. (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing important, ...
For the quarter ended December 2025, Allegiant Travel (ALGT) reported revenue of $656.19 million, up 4.5% over the same period last year. EPS came in at $2.86, compared to $2.10 in the year-ago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results